A phase 1 clinical trial of intraperitoneal administration of iCAR-ILC/N101 for ovarian clear cell carcinoma

General Information

Clinical trials phase Phase 1
Start date (estimated) 2021-05-10
Clinical feature
Label ovarian cancer
Link http://purl.obolibrary.org/obo/DOID_2394
Description A female reproductive organ cancer that is located_in the ovary.; Xref MGI. OMIM mapping confirmed by DO. [SN].

Administrative Information

ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCT2033200431
Other study identifiers
Name jRCT2033200431
Description Japan Registry of Clinical Trials (jRCT)
Source weblink https://jrct.niph.go.jp/en-latest-detail/jRCT2033200431
Public contact
Email GPC3-CAR_core@east.ncc.go.jp
Public email GPC3-CAR_core@east.ncc.go.jp
Last name Clinical Trial Coordinating Office
Phone +81-4-7133-1111
Address freetext National Cancer Center Hospital East 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba, 277-8577, Japan


Which differentiated cell type is used
Label natural killer cell
Link http://purl.obolibrary.org/obo/CL_0000623
Description A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.


Recruitment Status Recruiting
Estimated number of participants 18